Literature DB >> 11521979

Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance.

B Wallner1, A Sylvan, K G Janunger, B Bozoky, R Stenling.   

Abstract

BACKGROUND: Data from previous studies on intestinal metaplasia at the gastroesophageal junction have been conflicting, which makes the diagnosis of Barrett's esophagus less obvious. This may partly be due to the lack of a reliable classification of the Z-line appearance. We previously proposed such a classification (the ZAP classification) that was shown to correlate with the prevalence of intestinal metaplasia. The use of different immunohistochemical techniques has increased in the study of intestinal metaplasia. In the present study our aim was to 1) evaluate the impact of different antibodies, namely cytokeratin (CK) 7, 13, and 20, CaCO3/73, and FBB2/29, in order to differentiate between Barrett's esophagus and cardia intestinal metaplasia, and 2) explore the staining patterns in different ZAP grades.
METHODS: Thirty-nine specimens with intestinal metaplasia were compared--9 from Barrett's esophagus, 6 from cardia, and 24 from the Z-line. The Z-line specimens were evaluated with respect to ZAP grade.
RESULTS: No differences were encountered regarding staining patterns for CK13 and CaCO3/73 in Barrett's esophagus and cardia. The staining pattern of CK7/20 was significantly different between Barrett's esophagus and cardia. CK7/20 showed a rising frequency of Barrett's esophagus staining pattern with rising ZAP grade.
CONCLUSION: CK7/20 is a feasible marker for Barrett's esophagus. Intestinal metaplasia in different ZAP grades differs regarding expression of immunohistochemical markers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521979     DOI: 10.1080/003655201750305404

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection.

Authors:  A Oksanen; A Sankila; K von Boguslawski; P Sipponen; H Rautelin
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

3.  Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.

Authors:  Nicole M White; Manal Gabril; Gershon Ejeckam; Maria Mathews; John Fardy; Fady Kamel; Jules Doré; George M Yousef
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

Review 4.  The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review.

Authors:  Zhannat Nurgalieva; Angus Lowrey; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2007-03-21       Impact factor: 3.487

5.  Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea.

Authors:  Ji Hyun Kim; Jin Ki Hwang; Juhyung Kim; Sehe Dong Lee; Beom Jae Lee; Jae Seon Kim; Young-Tae Bak
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

6.  The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

Authors:  Ozlem Kurtkaya-Yapicier; Rasim Gencosmanoglu; Erol Avsar; Nadi Bakirci; Nurdan Tozun; Aydin Sav
Journal:  BMC Clin Pathol       Date:  2003-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.